Search
forResearch 10 of 1000+
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Outcome measure instruments for the assessment and treatment of androgenetic alopecia: A scoping review
- Content validity of five single‐item instruments in adolescents with alopecia areata
- The Spectrum of Health Domains Important to Lupus Patients Early Development of a Disease Activity Patient Reported Outcome.
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population
- Objective outcome measures: Collecting meaningful data on alopecia areata
- PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
- Development and validation of a patient‐reported outcome measure for hair loss treatment: The HAIR‐Q
- Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
Learn 2 of 25
All learn results →Community
— no results
Try a deeper search in community →